Tolvaptan Tablet
Product Images NDC 72603-933

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tolvaptan (NDC 72603-933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tolvaptan-15mg-blstr-crtn (Tolvaptan 15mg Blstr Crtn)

This text provides important details about Tolvaptan Tablets, including the dosage information (15 mg per tablet) and the recommendation to initiate treatment in a hospital setting. The medication guide should be given to each patient. The tablets are stored at a controlled room temperature between 15-30°C. The packaging includes 10 tablets in a strip. The product is manufactured by Northstar Rx LLC in collaboration with MSN Laboratories in India.*

FDA Label Image

Tolvaptan-15mg-blstr-foil (Tolvaptan 15mg Blstr Foil)

FDA Label Image

Tolvaptan-30mg-blstr-crtn (Tolvaptan 30mg Blstr Crtn)

This text provides information about Tolvaptan tablets, a medication that must be initiated in the hospital. The tablets contain 30 mg of Tolvaptan each. It includes instructions for pharmacists to dispense a Medication Guide to each patient and recommends storing the tablets at 25°C with excursions permitted between 15°C and 30°C. The text also mentions the manufacturer and includes the National Drug Code (NDC) for the product.*

FDA Label Image

Tolvaptan-30mg-blstr-foil (Tolvaptan 30mg Blstr Foil)

The text provides details about a medication called Tolvaptan Tablet, available in 30mg strength, manufactured for Northstar Rx in India. The tablet is labeled with NDC 72603-933-01 and has an issue date of 02/2026. Additionally, there are various alphanumeric codes and symbols indicated on the packaging.*

FDA Label Image

Tolvaptan-figure-1 (Tolvaptan Figure 1)

FDA Label Image

Tolvaptan-figure-2 (Tolvaptan Figure 2)

FDA Label Image

Tolvaptan-figure-3 (Tolvaptan Figure 3)

This text seems to present statistical data regarding serum sodium levels and tolvaptan usage. The mean serum sodium levels are shown over different time points, with a comparison to baseline levels. Tolvaptan at a dose of 15.60 mg was administered to 111 subjects. The statistical significance is highlighted with p<0.0001 compared to baseline. Day 1 and subsequent time points are also mentioned in the data. Washout possibly refers to a phase of discontinuing tolvaptan.*

FDA Label Image

Tolvaptan-structure (Tolvaptan Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.